Locating our reseach facilities at Nagoya University to create innovative new drugs for patients from Japan's Chubu region.

● Research facilities located at Nagoya University

We are accelerating drug discovery research by setting up our research facilities at Nagoya University, an institution that is well-recognized for its numerous Nobel laureates and cutting-edge science.

 

● Leveraging each of industry's and academia's strengths..

Our innovative drug discovery research programs are moving forward by combining the drug expertise of RaQualia Pharma and the state-of-the-art science and technologies available at Nagoya University. Furthermore, access to Nagoya University's clinical facilities enables us to implement rapid and seamless research activities, from basic research to clinical studies.

 

● Further Expansion of Industry-Academia Collaboration

We promote collaborative research not only with Nagoya University, but also with other universities and institutes in Japan and the world.

Accelerating Drug Discovery Research Through Industry-Academia Collaboration

"RaQualia Pharma Industry-Academia Collaborative Research Center" was established at Nagoya University in April 2018

Department of Pharmacology

1. Evaluation of the pharmacological efficacy of drugs
2. Studies on mechanism of action (MOA) of drug targets

Department of Pharmaceutical Sciences

1. Research on the design of new drug candidate compounds and organic synthesis technologies
2. Study on pharmaceutical sciences and analytical chemistry

In April 2018, we launched the first industry-academia collaborative research center at Nagoya University by integrating the former three departments/labs, organized as the Research Institute of Environmental Medicine (RIeM), Graduate School of Medicine, and Graduate School of Pharmaceutical Sciences of Nagoya University, into two departments in RIeM.